CPT 82947: Blood Glucose Quantitative Test, Non-Reagent Strip
Commercial payers pay $9 on average nationally for this procedure.
CPT code 82947 describes a laboratory quantitative measurement of blood glucose performed by a lab analyst using a method other than a reagent strip; service type: clinical laboratory test (quantitative glucose assay); typical site of service: hospital laboratory or independent reference/clinical laboratory (non-point-of-care) where instrumented analytic methods are used.
For related coverage guidance, see recent payer policy updates: Salivary Hormone Testing, Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing, Bone Turnover Markers Testing.
Customize your policy alerts
Sign up for cpt 82947 policy alerts
Get alerted when payer policies referencing 82947 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial reimbursement for CPT 82947 centers around a BUCA mean of $8.9, indicating a mid-range commercial average for this chemistry panel. Blue Cross Blue Shield shows the highest central tendency with a median of $9 and a relatively wide upper tail to a $64.2 maximum; Aetna and Cigna sit lower with medians at $4 and $4.6 respectively, while UnitedHealth Group’s median of $3.9 aligns closely with Cigna. Overall commercial averages congregate in the $4–$12 area, with BUCA at $8.9 serving as a useful midpoint reference.
Rate dispersion, measured as P75 minus P25, is narrowest for UnitedHealth Group (P75 $4.70 minus P25 $2.40 = $2.30) and Cigna (P75 $5.60 minus P25 $3.10 = $2.50), indicating tighter negotiated bands. The widest dispersion appears with Blue Cross Blue Shield (P75 $13.70 minus P25 $6.80 = $6.90) and Aetna (P75 $7.20 minus P25 $3.00 = $4.20), suggesting greater variability in commercial contract outcomes across markets.